Literature DB >> 3090587

Effects of repeated administration of the monoamine oxidase inhibitor phenelzine on the discriminability of d-lysergic acid diethylamide (LSD) and 1-(m-trifluoromethylphenyl) piperazine (TFMPP).

K A Cunningham, B A Carroll, J B Appel.   

Abstract

Rats trained to discriminate d-lysergic acid diethylamide (LSD; 0.08 mg/kg) or 1-(m-trifluoromethylphenyl) piperazine (TFMPP; 0.8 mg/kg) were treated with the monoamine oxidase inhibitor (MAOI) phenelzine (10 mg/kg/day) for 7 days. After a 24 h "washout" period, they were challenged with the training drug (and dose) or saline, during extinction test sessions. Following 0.08 mg/kg LSD, LSD-trained rats responded primarily on the saline lever (29% drug-appropriate responding) while, after TFMPP (0.8 mg/kg), TFMPP-trained animals responded on the drug lever (75% drug-appropriate responding). These preliminary data suggest that, if serotonin receptors are involved in the behavioral effects of TFMPP, these receptors differ from those involved in the effects of LSD.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090587     DOI: 10.1007/bf00175206

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  3 in total

1.  Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding.

Authors:  S J Peroutka; S H Snyder
Journal:  Science       Date:  1980-10-03       Impact factor: 47.728

2.  5-Hydroxytryptamine (5-HT)-dependent myoclonus in guinea pigs is induced through brainstem 5-HT-1 receptors.

Authors:  G Luscombe; P Jenner; C D Marsden
Journal:  Neurosci Lett       Date:  1984-02-24       Impact factor: 3.046

3.  Antagonism of the LSD cue by putative serotonin antagonists: relationship to inhibition of in vivo [3H]spiroperidol binding.

Authors:  E B Nielsen; S R Ginn; K A Cunningham; J B Appel
Journal:  Behav Brain Res       Date:  1985-08       Impact factor: 3.332

  3 in total
  2 in total

1.  Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984-1987.

Authors:  I P Stolerman; F Rasul; P J Shine
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Determining the subjective effects of TFMPP in human males.

Authors:  Reem K Jan; Joanne C Lin; Heeseung Lee; Janie L Sheridan; Rob R Kydd; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2010-06-16       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.